Pages that link to "Q79961081"

The following pages link to Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets (Q79961081):

Displaying 36 items.

• Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma (Q24651026) (← links)
• Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer (Q26824316) (← links)
• Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells (Q28264565) (← links)
• High and low dose radiation effects on mammary adenocarcinoma cells - an epigenetic connection (Q28394677) (← links)
• High-definition DNA methylation profiles from breast and ovarian carcinoma cell lines with differing doxorubicin resistance (Q28474284) (← links)
• Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer (Q33463860) (← links)
• The down-regulation of SLC7A11 enhances ROS induced P-gp over-expression and drug resistance in MCF-7 breast cancer cells (Q33812772) (← links)
• DNA hypomethylation in cancer cells (Q33862334) (← links)
• Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells (Q34566017) (← links)
• Epigenetic changes associated with inflammation in breast cancer patients treated with chemotherapy (Q35034170) (← links)
• Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway (Q35067970) (← links)
• SUV420H2-mediated H4K20 trimethylation enforces RNA polymerase II promoter-proximal pausing by blocking hMOF-dependent H4K16 acetylation (Q35077092) (← links)
• MicroRNA-mediated drug resistance in breast cancer (Q35165126) (← links)
• Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy (Q35212176) (← links)
• DNA Methylation and Flavonoids in Genitourinary Cancers (Q35623184) (← links)
• Epigenetic modulation of the biophysical properties of drug-resistant cell lipids to restore drug transport and endocytic functions (Q36207846) (← links)
• Prognostic and predictive significance of long interspersed nucleotide element-1 methylation in advanced-stage colorectal cancer (Q36220792) (← links)
• Tissue transglutaminase: a new target to reverse cancer drug resistance (Q36503511) (← links)
• Drug resistance and the role of combination chemotherapy in improving patient outcomes (Q36999509) (← links)
• Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets (Q37352004) (← links)
• Troglitazone reverses the multiple drug resistance phenotype in cancer cells. (Q37403238) (← links)
• Decitabine impact on the endocytosis regulator RhoA, the folate carriers RFC1 and FOLR1, and the glucose transporter GLUT4 in human tumors (Q37493954) (← links)
• Novel antioxidants are not toxic to normal tissues but effectively kill cancer cells (Q37589229) (← links)
• Multidrug-resistant breast cancer: current perspectives (Q37593383) (← links)
• The epigenetics of breast cancer (Q37772356) (← links)
• MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy (Q38172970) (← links)
• Biology and Treatment of Rhabdoid Tumor (Q38582867) (← links)
• Diverse effects of G-protein-coupled free fatty acid receptors on the regulation of cellular functions in lung cancer cells (Q38787019) (← links)
• Identification of hypermethylated genes associated with cisplatin resistance in human cancers (Q39730118) (← links)
• Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemia. (Q41781135) (← links)
• EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming (Q47600932) (← links)
• Lysophosphatidic acid signaling via LPA1 and LPA3 regulates cellular functions during tumor progression in pancreatic cancer cells. (Q50897995) (← links)
• Enhanced cellular functions through induction of LPA2 by cisplatin in fibrosarcoma HT1080 cells. (Q51002375) (← links)
• Determination of the presence of 5-methylcytosine in Paramecium tetraurelia (Q58090964) (← links)
• Histone 4 Lysine 20 Methylation: A Case for Neurodevelopmental Disease (Q64070328) (← links)
• Perplexing Role of P-Glycoprotein in Tumor Microenvironment (Q90484035) (← links)